Gammalon vs Aminalon: what to choose?
Gammalon vs Aminalon: what is the difference?
Aminalon is sold in Europe and some CIS countries like Russia and Ukraine. The basic component of Aminalon is identical to the Japanese Gammalon’s active component. The dosage of active substance in of both medicines is the almost same. In this regard, many are wondering what is the point of buying a more expensive Gammalon when it is enough to purchase Aminalon that is significantly cheaper. However, things are not so simple as they seem to be.
The main differences between Gammalon and Aminalon: pharmacological approach.
There are three principal differences between Gammalon and Aminalon. However, those three points play a crucial role in the treatment of serious diseases. In particular, if you conduct a course of intensive treatment of children or the elderly Gammalon will show much more therapeutic effects with much less side effects. All three factors are due to simple technological differences in the production processes at the plants of Daiichi Sankyo Pharma and its sub-divisions Alfres, and of the factories producing Aminalon in other countries. Below are three basic factors that differentiate the difference of those medicines:
- The place of manufacture of raw material, gamma-aminobutyric acid.
- The degree of purification of raw materials during manufacturing process.
- The degree and severity of side effects caused by medicine.
The first and most important difference between Gammalon and Aminalon is the degree of purification of the raw materials used in manufacturing process. With the first factor, everything is quite clear. Raw materials for Aminalon is imported from China. On the wholesale websites of the People's Republic of China there are hundreds of suppliers selling these raw materials in kilograms and centers (just check our Alibaba website and you will see it). Of course, its quality is rather poor, companies buy low quality product at low price. Gammalon, on the other hand, is manufactured from raw materials produced on Japanese factory, a domestic plant with full quality control; process and in compliance with all global standards and safety techniques.
The degree of active substance’s purification of Aminalon and Gammalon is also different. It is not enough to buy high-quality raw materials, it is necessary to purify it completely, clearing out even the smallest impurities. Remember, even insignificant concentrations of foreign substances of thousandths of a microgram can cause uncontrolled reactions and undo therapeutic effects completely. The technologies of the Daiichi Sankyo concern have evolved since 1899, when the First Pharmaceutical Company was founded in Tokyo (Daiichi Pharmaceutical Concern), which later became the basis for today’s Daiichi Sankyo group. They started to manufacture Gammalon back in 1950, no wonder their technologies are far ahead of all those available in Europe and CIS or China.
The third point is caused by the second point - insufficient degree of purification causes unexpected side effects, reduces the expected therapeutic results and leads to undesirable consequences. Any pharmacist is aware of the danger of substandard goods. In recent years, India started to manufacture a lot of medicines from around the world. However, they are completely ineffective in many cases. Many medicines require highest purification and accurate technologies to achieve subtle effects and work with the nervous system and mental aspects of patients.
Remember Gammalon medicine is certified in Japan, it passed clinical trials in Japan and today it is popular all over the world due to it’s high efficiency. It is not worth risking the health of your loved ones by choosing cheaper analogues if there is the slightest opportunity to purchase a high-quality genuine Gammalon from Japan. Of course, if there is no financial opportunity, you should use the available options, but when using Aminalon, watch for your condition, and for possible side effects. In case they occurre stop taking the medicine immediately, and consult with your doctor.
You may also check the following related articles in our blog:
Clinical studies of the Gammalon.